231 related articles for article (PubMed ID: 27267836)
1. Increased Expression of PHGDH and Prognostic Significance in Colorectal Cancer.
Jia XQ; Zhang S; Zhu HJ; Wang W; Zhu JH; Wang XD; Qiang JF
Transl Oncol; 2016 Jun; 9(3):191-6. PubMed ID: 27267836
[TBL] [Abstract][Full Text] [Related]
2. High Expression of PHGDH Predicts Poor Prognosis in Non-Small Cell Lung Cancer.
Zhu J; Ma J; Wang X; Ma T; Zhang S; Wang W; Zhou X; Shi J
Transl Oncol; 2016 Dec; 9(6):592-599. PubMed ID: 27916294
[TBL] [Abstract][Full Text] [Related]
3. Phosphoglycerate dehydrogenase is a novel predictor for poor prognosis in gastric cancer.
Xian Y; Zhang S; Wang X; Qin J; Wang W; Wu H
Onco Targets Ther; 2016; 9():5553-60. PubMed ID: 27660473
[TBL] [Abstract][Full Text] [Related]
4. The clinical significance of CCBE1 expression in human colorectal cancer.
Zhao YR; Liu H; Xiao LM; Jin CG; Zhang ZP; Yang CG
Cancer Manag Res; 2018; 10():6581-6590. PubMed ID: 30555263
[TBL] [Abstract][Full Text] [Related]
5. CILP2 overexpression correlates with tumor progression and poor prognosis in patients with colorectal cancer in The Cancer Genome Atlas (TCGA) study.
Huang F; Peng Y; Ye Q; Chen J; Li Y; Liu S; Xu Y; Huang L
World J Surg Oncol; 2020 Oct; 18(1):274. PubMed ID: 33099318
[TBL] [Abstract][Full Text] [Related]
6. Aberrant expression of stress-induced phosphoprotein 1 in colorectal cancer and its clinicopathologic significance.
Zhang Z; Ren H; Yang L; Zhang X; Liang W; Wu H; Huang L; Kang J; Xu J; Zhai E; Cai S; He Y
Hum Pathol; 2018 Sep; 79():135-143. PubMed ID: 29879402
[TBL] [Abstract][Full Text] [Related]
7. CYP24A1 is a potential biomarker for the progression and prognosis of human colorectal cancer.
Sun H; Wang C; Hao M; Sun R; Wang Y; Liu T; Cong X; Liu Y
Hum Pathol; 2016 Apr; 50():101-8. PubMed ID: 26997443
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive analysis of PHGDH for predicting prognosis and immunotherapy response in patients with endometrial carcinoma.
Zhang H; Kong W; Zhao X; Xie Y; Luo D; Chen S
BMC Med Genomics; 2023 Feb; 16(1):29. PubMed ID: 36803157
[TBL] [Abstract][Full Text] [Related]
9. High expression of PFTK1 in cancer cells predicts poor prognosis in colorectal cancer.
Mao Y; Jia Y; Zhu H; Wang W; Jin Q; Huang F; Zhang S; Li X
Mol Med Rep; 2017 Jul; 16(1):224-230. PubMed ID: 28498444
[TBL] [Abstract][Full Text] [Related]
10. CXCL10 expression and prognostic significance in stage II and III colorectal cancer.
Jiang Z; Xu Y; Cai S
Mol Biol Rep; 2010 Jul; 37(6):3029-36. PubMed ID: 19821051
[TBL] [Abstract][Full Text] [Related]
11. Expression of Aldehyde Dehydrogenase 1A1 (ALDH1A1) as a Prognostic Biomarker in Colorectal Cancer Using Immunohistochemistry.
Yang W; Wang Y; Wang W; Chen Z; Bai G
Med Sci Monit; 2018 May; 24():2864-2872. PubMed ID: 29748529
[TBL] [Abstract][Full Text] [Related]
12. Aldehyde dehydrogenase 1 expression is correlated with poor prognosis in breast cancer.
Yao J; Jin Q; Wang XD; Zhu HJ; Ni QC
Medicine (Baltimore); 2017 Jun; 96(25):e7171. PubMed ID: 28640095
[TBL] [Abstract][Full Text] [Related]
13. PHGDH knockdown increases sensitivity to SR1, an aryl hydrocarbon receptor antagonist, in colorectal cancer by activating the autophagy pathway.
Li HM; Li X; Xia R; Zhang X; Jin TZ; Zhang HS
FEBS J; 2024 Apr; 291(8):1780-1794. PubMed ID: 38317509
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of gene DEP domain containing 1 and its clinical prognostic significance in colorectal cancer.
Shen X; Han J
J Clin Lab Anal; 2020 Dec; 34(12):e23634. PubMed ID: 33140894
[TBL] [Abstract][Full Text] [Related]
15. KIF2A overexpression and its association with clinicopathologic characteristics and unfavorable prognosis in colorectal cancer.
Fan X; Wang X; Zhu H; Wang W; Zhang S; Wang Z
Tumour Biol; 2015 Nov; 36(11):8895-902. PubMed ID: 26070867
[TBL] [Abstract][Full Text] [Related]
16. Hsa_circ_0062682 Promotes Serine Metabolism and Tumor Growth in Colorectal Cancer by Regulating the miR-940/PHGDH Axis.
Sun S; Li C; Cui K; Liu B; Zhou M; Cao Y; Zhang J; Bian Z; Fei B; Huang Z
Front Cell Dev Biol; 2021; 9():770006. PubMed ID: 34957102
[TBL] [Abstract][Full Text] [Related]
17. The relationship between TESTIN expression and the prognosis of colorectal cancer.
Zhu Y; Qiao Q
Pathol Res Pract; 2022 Apr; 232():153744. PubMed ID: 35219152
[TBL] [Abstract][Full Text] [Related]
18. Up-regulation of mir-10b predicate advanced clinicopathological features and liver metastasis in colorectal cancer.
Jiang H; Liu J; Chen Y; Ma C; Li B; Hao T
Cancer Med; 2016 Oct; 5(10):2932-2941. PubMed ID: 27592860
[TBL] [Abstract][Full Text] [Related]
19. Eukaryotic elongation factor-2 kinase expression is an independent prognostic factor in colorectal cancer.
Ng TH; Sham KWY; Xie CM; Ng SSM; To KF; Tong JHM; Liu WYZ; Zhang L; Chan MTV; Wu WKK; Cheng CHK
BMC Cancer; 2019 Jul; 19(1):649. PubMed ID: 31266475
[TBL] [Abstract][Full Text] [Related]
20. High expression of AMPD2 and obesity are associated with poor prognosis in colorectal cancer.
Wang F; Liu Y; Jiang J; Qin Y; Ge X; Li J; Qi X; Mao Y
Int J Clin Exp Pathol; 2018; 11(1):216-223. PubMed ID: 31938103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
